BiVacor announced today that it received FDA breakthrough device designation for its Total Artificial Heart (TAH) system.

Boston Scientific has discontinued global sales of its Acurate neo2 and Acurate Prime transcatheter aortic valve replacement ...

Abbott (NYSE: ABT) announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR ...

Terumo Interventional Systems has announced the early commercial availability of its FDA-approved Roadsaver Carotid Stent ...

Reflow Medical received FDA de novo clearance for its Spur Peripheral Retrievable Stent System for infrapopliteal arterial ...

BioSig has merged with Streamex Exchange Corp. in a move that will take the British Columbia–based commodities tokenization ...

Johnson & Johnson MedTech (NYSE: JNJ) today announced results from a study of its Monarch platform for robotic bronchoscopy ...

Vivani Medical (Nasdaq:VANI) announced that it filed a Form 10 registration statement with the SEC to spin off its ...

Camille Chang Gilmore, Boston Scientific’s global chief DEI officer announced she is leaving the company after two decades of ...

Add Medtronic to the growing list of companies and institutions rolling back the work-from-home movement that outlasted the ...

Dentsply Sirona this week announced it appointed Matthew Garth as EVP and chief financial officer, effective today.

The Financial Times reported yesterday that a duo of private equity firms approached Hologic (Nasdaq: HOLX) about a potential ...